Clinical Trial Update: Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of allopurinol on urinary biomarkers and renal parameters after ESWL in kidney stone patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Calculi
• Kidney Stone Disease

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Sanglah General Hospital | Conditions: Kidney Calculi | Phase 4 | Status: COMPLETED